Infinitopes Triumphs with Prestigious Recognition at OBN Awards: A Celebration of Excellence

In a moment of gratitude and reflection, Infinitopes proudly shares the news of our dual triumph at the OBN Awards 2023, hosted by OBN (UK) Ltd. on November 22nd.

Best Biotech Start-up 2023

The acknowledgment as the "Best Biotech Start-Up 2023" is not just a win for Infinitopes; it's a shared victory with our dedicated team, supportive partners, and the entire biotech community. This award reflects the collective spirit that propels us forward in our mission. It is a testament to the excellence of our founding team, whose vision and relentless drive have been instrumental in our journey. Their leadership has not only guided Infinitopes but has also set a benchmark for innovation and perseverance.

OBN BioSeed One to Watch

The "OBN BioSeed One to Watch" honour is both a recognition of Infinitopes' emerging potential and a tribute to the collective effort behind our progress. It underscores the invaluable contributions of our Scientific Advisory Board (SAB) and each team member, whose unparalleled dedication and expertise are pivotal in bringing our vision closer to reality. This distinction not only highlights our future prospects but also the solid foundation laid by our entire team's unwavering commitment to innovation in cancer research.

Celebrating these accomplishments, Infinitopes is inspired to forge ahead with even greater resolve towards our goal of eradicating cancer. Each accolade strengthens our resolve to deliver ground-breaking solutions, reflecting the exceptional skill and persistent endeavour of our team and advisory board in shaping a hopeful future.

Share this post
We use cookies to improve your experience on our website. You can accept all the cookies, reject them or select your cookie preferences by clicking the corresponding buttons. For more information, please see our cookie policy.